poisar

Stocks · News reference

Jaguar Health shares are trading lower after the company announced all pediatric MVID patients in pivotal crossover clinical trial have entered the extension phase to receive blinded doses of crofelemer.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading